Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » PierianDx, Pillar Biosciences Partner to Streamline NGS Cancer Analysis

PierianDx, Pillar Biosciences Partner to Streamline NGS Cancer Analysis

Oct 14, 2020
|
staff reporter

NEW YORK – PierianDx will integrate the Pillar Biosciences PiVAT cancer bioinformatics pipeline into its core technology platform, the companies announced Wednesday. Under the new partnership, Pillar Bio, which has co-headquarters in Boston and Shanghai, will market PieranDx clinical genomic reports along with its own cancer profiling assays.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Even Bigger

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Got Into the Lab Machines

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Not Going to Pay

Science reports that a Dutch research funding agency is combating a ransomware attack.

Science Papers Present Haplotype-Resolved Genomes, MiRNA-Linked Complex Tied to Ribosomal Protein Production

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.

What's Popular?

In Business News

  1. Luminex Shares Surge on Rumor of Acquisition by DiaSorin

  2. 10x Genomics Acquires Denmark's Tetramer Shop

  3. Miroculus Raises $45M in Extended Series B Financing

  4. Guardant Health Q4 Revenues Up 25 Percent

  5. GenMark Diagnostics Q4 Revenues Rise 84 Percent on MDx Sales

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.